In accordance with the Centers for Disease Control and Prevention, over 37 million people within the US have diabetes. That is just over 11% of the full population.
The diabetic body doesn’t produce enough insulin or doesn’t produce it in any respect. Individuals with this condition need to observe their blood sugar often. Traditionally, this has been done with blood glucose meters, which diabetics use to repeatedly prick their fingers for a drop of blood. But over the past decade, technology similar to continuous glucose monitoring has been advancing.
Abbott AND Dexcom they are the 2 most dominant players within the space. Each firms recorded accelerated growth.
The technology can be marketed by several health and wellness apps as many firms see advantages for individuals who haven’t got diabetes.
CNBC spoke with each Abbott and Dexcom concerning the technology utilized in continuous glucose monitors and its development.
Watch the video to learn more.